Seasonal influenza can poise hosts for CD4 T-cell immunity to H7N9 avian influenza

Journal of Infectious Diseases

Volumn 212, Issue 1, 2015, Pages 86-94

  Richards, Katherine A ^a   Nayak, Jennifer ^a   Chaves, Francisco A ^a   Dipiazza, Anthony ^a   Knowlden, Zackery A G ^a   Alam, Shabnam ^a   Treanor, John J ^b   Sant, Andrea J ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b Infectious Disease Unit   (United States)

Author keywords

CD4 T cells; H7N9; Influenza; vaccines.

Indexed keywords

INFLUENZA VACCINE; VIRUS HEMAGGLUTININ;

ADULT; ANTIBODY PRODUCTION; ARTICLE; AVIAN INFLUENZA; CD4+ T LYMPHOCYTE; CELL ISOLATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN CELL; INFLUENZA A; INFLUENZA A (H7N9); INFLUENZA VACCINATION; INFLUENZA VIRUS A H7N9; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SEASONAL INFLUENZA; VIRUS STRAIN; ADOLESCENT; ANIMAL; HETEROLOGOUS IMMUNITY; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; INFLUENZA; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); INFLUENZA A VIRUS (H7N9); MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CROSS REACTIONS; HUMANS; IMMUNITY, HETEROLOGOUS; IMMUNOLOGIC MEMORY; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA, HUMAN; MIDDLE AGED; YOUNG ADULT;

EID: 84936751939     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu662     Document Type: Article

References (42)

1. Wang Y, Dai Z, Cheng H, et al. Towards a better understanding of the novel avian-origin H7N9 influenza A virus in China. Sci Rep 2013; 3:2318-28.
2. Gao R, Cao B, Hu Y, et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 2013; 368:1888-97.
3. Kageyama T, Fujisaki S, Takashita E, et al. Genetic analysis of novel avian A(H7N9) influenza viruses isolated from patients in China, February to April 2013. Euro Surveill 2013; 18:20453.
4. Liu D, ShiW, Shi Y, et al. Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: phylogenetic, structural, and coalescent analyses. Lancet 2013; 381:1926-32.
5. Zhu H, Wang D, Kelvin DJ, et al. Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs. Science 2013; 341:183-6.
6. Zhang Q, Shi J, Deng G, et al. H7N9 influenza viruses are transmissible in ferrets by respiratory droplet. Science 2013; 341:410-4.
7. Watanabe T, Kiso M, Fukuyama S, et al. Characterization of H7N9 influenza A viruses isolated from humans. Nature 2013; 501:551-5.
8. Morens DM, Taubenberger JK, Fauci AS. H7N9 avian influenza Avirus and the perpetual challenge of potential human pandemicity. MBio 2013; 4-8.
9. Steinhauer DA. Influenza: pathways to human adaptation. Nature 2013; 499:412-3.
10. Jennings LC. Influenza vaccines: an Asia-Pacific perspective. Influenza Other Respir Viruses 2013; 7(suppl 3):44-51.
11. Osterholm MT, Ballering KS, Kelley NS. Major challenges in providing an effective and timely pandemic vaccine for influenza A(H7N9). JAMA 2013; 309:2557-8.
12. Sant AJ, McMichael A. Revealing the role of CD4+ T cells in viral immunity. J Exp Med 2012; 209:1391-5.
13. Swain SL, McKinstry KK, Strutt TM. Expanding roles for CD4+ T cells in immunity to viruses. Nat Rev Immunol 2012; 12:136-48.
14. Sun J, Braciale TJ. Role of T cell immunity in recovery from influenza virus infection. Curr Opin Virol 2013; 3:425-9.
15. Strutt TM, McKinstry KK, Swain SL. Control of innate immunity by memory CD4 T cells. Adv Exp Med Biol 2011; 780:57-68.
16. Teijaro JR, Verhoeven D, Page CA, Turner D, Farber DL. Memory CD4 T cells direct protective responses to influenza virus in the lungs through helper-independent mechanisms. J Virol 2010; 84:9217-26.
17. Ma CS, Deenick EK, Batten M, Tangye SG. The origins, function, and regulation of T follicular helper cells. J Exp Med 2012; 209:1241-53.
18. Nayak JL, Fitzgerald TF, Richards KA, Yang H, Treanor JJ, Sant AJ. CD4+ T-cell expansion predicts neutralizing antibody responses to monovalent, inactivated 2009 pandemic influenza A(H1N1) virus subtype H1N1 vaccine. J Infect Dis 2013; 207:297-305.
19. Bentebibel SE, Lopez S, Obermoser G, et al. Induction of ICOS+ CXCR3+CXCR5+ TH cells correlates with antibody responses to influenza vaccination. Sci Transl Med 2013; 5:176-32.
20. Alam S, Knowlden ZA, Sangster MY, Sant AJ. CD4 T cell help is limiting and selective during the primary B cell response to influenza virus infection. J Virol 2014; 88:314-24.
21. Richards KA, Chaves FA, Sant AJ. Infection ofHLA-DR1 transgenicmice with a human isolate of influenza a virus (H1N1) primes a diverse CD4 T-cell repertoire that includes CD4 T cells with heterosubtypic crossreactivity to avian (H5N1) influenza virus. J Virol 2009; 83:6566-77.
22. Richards KA, Topham D, Chaves FA, Sant AJ. Cutting edge: CD4 T cells generated from encounter with seasonal influenza viruses and vaccines have broad protein specificity and can directly recognize naturally generated epitopes derived from the live pandemic H1N1 virus. J Immunol 2010; 185:4998-5002.
23. Rudolph MG, Stanfield RL, Wilson IA. How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol 2006; 24:419-66.
24. Nielsen M, Lund O, Buus S, Lundegaard C. MHC class II epitope predictive algorithms. Immunology 2010; 130:319-28.
25. Nabel GJ, Fauci AS. Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccine.Nat Med 2010; 16:1389-91.
26. Nayak JL, Richards KA, Chaves FA, Sant AJ. Analyses of the specificity of CD4 T cells during the primary immune response to influenza virus reveals dramatic MHC-linked asymmetries in reactivity to individual viral proteins. Viral Immunol 2010; 23:169-80.
27. Richards KA, Chaves FA, AlamS, Sant AJ. Trivalent inactivated influenza vaccines induce broad immunological reactivity to both internal virion components and influenza surface proteins. Vaccine 2012; 31:219-25.
28. Mulligan MJ, Bernstein DI, Winokur P, Rupp R, et al. Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-ofuse with MF59 adjuvant: a randomized clinical trial. JAMA 2014; 312:1409-19.
29. Rudenko L, Kiseleva I, Naykhin AN, Erofeeva M, et al. Assessment of human immune responses to H7 avian influenza virus of pandemic potential: results from a placebo-controlled, randomized double-blind phase I study of live attenuated H7N3 influenza vaccine. PLoS One 2014; 9:e87962.
30. Couch RB, Patel SM, Wade-Bowers CL, Nino D. A randomized clinical trial of an inactivated avian influenza A (H7N7) vaccine. PLoS One 2012; 7:e49704.
31. Nayak JL, Richards KA, Yang H, Treanor JJ, Sant AJ. Effect of influenza A(H5N1) vaccine prepandemic priming on CD4+ T-cell responses. J Infect Dis 2015; 211:1408-17.
32. Kim Y, Ponomarenko J, Zhu Z, Tamang D, et al. Immune epitope database analysis resource. Nucleic Acids Res 2012; 40:W525-30.
33. Huseby ES, White J, Crawford F, et al. How the T cell repertoire becomes peptide and MHC specific. Cell 2005; 122:247-60.
34. Richards KA, Chaves FA, Krafcik FR, Topham DJ, Lazarski CA, Sant AJ. Direct ex vivo analyses of HLA-DR1 transgenic mice reveal an exceptionally broad pattern of immunodominance in the primary HLA-DR1-restricted CD4 T-cell response to influenza virus hemagglutinin. J Virol 2007; 81:7608-19.
35. De Groot AS, Ardito M, Terry F, et al. Low immunogenicity predicted for emerging avian-origin H7N9: implication for influenza vaccine design. Hum Vaccin Immunother 2013; 9:950-6.
36. Chaves FA, Lee AH, Nayak JL, Richards KA, Sant AJ. The utility and limitations of current Web-available algorithms to predict peptides recognized by CD4 T cells in response to pathogen infection. J Immunol 2012; 188:4235-48.
37. Wang P, Sidney J, Kim Y, et al. Peptide binding predictions for HLA DR, DP and DQ molecules. BMC Bioinformatics 2010; 11:568.
38. Rogers PR, Dubey C, Swain SL. Qualitative changes accompany memory T cell generation: faster, more effective responses at lower doses of antigen. J Immunol 2000; 164:2338-46.
39. MacLeod MK, Kappler JW, Marrack P. Memory CD4 T cells: generation, reactivation and re-assignment. Immunology 2010; 130:10-5.
40. London CA, Lodge MY, Abbas AK. Functional responses and costimulator dependence of memory CD4+ T cells. J Immunol 2000; 164: 265-72.
41. Lai W, Yu M, Huang MN, Okoye F, Keegan AD, Farber DL Transcriptional control of rapid recall by memory CD4 T cells. J Immunol 2011; 187:133-40.
42. Kumar R, Ferez M, Swamy M, et al. Increased sensitivity of antigen-experienced T cells through the enrichment of oligomeric T cell receptor complexes. Immunity 2011; 35:375-87.